Novo Nordisk Targets 'Obesity Disease Market' Despite Commercial Doubts

 
• By Sten Stovall

Novo Nordisk is targeting obesity as a key disease market, but its CEO says global alliances are needed in future to help fight the global pandemic, including the food industry.

Overweight stomach (shallow focus)
Diabetes Fighter Novo Nordisk Says It Will Increasingly Target Obesity • Source: Shutterstock

More from Strategy

More from Business